SAMH
MRNA icon

Shanda Asset Management Holdings’s Moderna MRNA Stock Holding History

Shanda Asset Management Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-300,000
Closed -$14M – 10
2025
Q4 		$8.85M Buy
+300,000
New +$8.15M 0.43% 8
2025
Q2 		– Sell
-1,000,000
Closed -$28.4M – 8
2025
Q1 		$28.4M Buy
+1,000,000
New +$35.5M 1.73% 6
2020
Q3 		– Sell
-60,000
Closed -$3.85M – 86
2020
Q2 		$3.85M Buy
+60,000
New +$3.29M 0.35% 47

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Shanda Asset Management Holdings's MRNA Position: Q1 2026 in Review

Shanda Asset Management Holdings sold out of Moderna (MRNA) in Q1 2026, closing a stake of 300,000 shares — an estimated $14M sold.

Shanda Asset Management Holdings first reported a position in MRNA in Q2 2020 and held it in 3 quarters. The position peaked at $28.4M in Q1 2025. 725 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Shanda Asset Management Holdings reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 300,000 Moderna shares in Q1 2026, an estimated $14M.
  • Shanda Asset Management Holdings first reported a position in Moderna in Q2 2020 and held it in 3 quarters.
  • Shanda Asset Management Holdings's Moderna position peaked at $28.4M in Q1 2025.
  • 725 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Shanda Asset Management Holdings's 13F filing for Q1 2026, filed 15 May 2026.